Top 50 Life Science Startup Investors in Germany (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
7 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $1.1M–$33M |
|
coparion
VC Fund
|
5 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
IFB Innovationsstarter
VC Fund
|
5 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Lima Ventures
VC Fund
|
3 | Turkey, United Kingdom, Estonia | Seed, Pre-Seed | Artificial Intelligence, Software, E-Commerce | $18k–$697k |
|
IBB Ventures
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$10M |
|
b.value AG
VC Fund
|
3 | Germany, Poland | Seed, Series A | Biotechnology, Manufacturing, Chemical | $478k–$39M |
|
Elevat3 Capital
VC Fund
|
3 | Germany, United Kingdom | Series A, Series B, Post-IPO Equity | FinTech, Apps, Social | $45M–$157M |
|
CPT Capital
VC Fund
|
3 | United States, Israel, United Kingdom | Seed, Series A, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Lowercarbon Capital
VC Fund
|
3 | United States, United Kingdom, France | Seed, Series A, Series B | Renewable Energy, Energy, Biotechnology | $3.7M–$150M |
|
Grazia Equity
VC Fund
|
3 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
Good Seed Ventures
VC Fund
|
3 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $25k–$21M |
|
Agronomics
VC Fund
|
3 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$20M |
|
Boost VC
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Software, Artificial Intelligence, Virtual Reality | $100k–$6.6M |
|
Albert Wenger
Angel
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Software, Analytics, Manufacturing | $650k–$38M |
|
hiVC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed, Series A | SaaS, Mobile, Rental | $175k–$850k |
|
EQT Group
VC Fund
|
2 | Germany | Series A | Life Science, Biotechnology, Food and Beverage | $46M–$50M |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Angel, Pre-Seed | Health Care, Medical Device, Medical | |
|
1kx
VC Fund
|
2 | United States, Germany, Switzerland | Seed, Series A | Blockchain, Cryptocurrency, Software | $1.8M–$28M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
Nico Wittenborn
Angel
|
2 | United States, Germany, France | Seed, Series A, Series B | Software, Apps, Wellness | $1.6M–$88M |
|
Ersin Pamuksüzer
Angel
|
2 | Turkey, Germany | Seed, Series A | Education, Life Science, Virtual Reality | $300k–$500k |
|
KfW
VC Fund
|
2 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Chemovator
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Software, Manufacturing, Advanced Materials | $975k–$3.7M |
|
TechOne VC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed | Software, SaaS, Information Technology | $30k–$2.8M |
|
Inflection
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Pre-Seed | Blockchain, Cryptocurrency, Software | $500k–$13M |
|
Holger Hübner
Angel
|
2 | Germany | Seed, Pre-Seed | B2B, SaaS, Audio | $177k–$987k |
|
Ananda Impact Ventures
VC Fund
|
2 | Germany, United Kingdom, Finland | Seed, Series A | Health Care, Software, Information Technology | $1.6M–$18M |
|
Michael Novogratz
Angel
|
2 | United States, India, Germany | Seed, Series A | Blockchain, FinTech, Cryptocurrency | $953k–$38M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Die Brückenköpfe
VC Fund
|
2 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $2M–$19M |
|
Shine Capital
VC Fund
|
2 | United States, Spain, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $3.5M–$71M |
|
Happiness Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Food and Beverage, Life Science | $2M–$61M |
|
Zee Prime Capital
VC Fund
|
2 | United States, Singapore, United Kingdom | Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $1.9M–$43M |
|
Lionheart Ventures
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A | Health Care, Biotechnology, Wellness | $25k–$46M |
|
Investitionsbank Berlin
VC Fund
|
2 | Germany, Canada | Grant, Seed | Software, Information Technology, Artificial Intelligence | $19k–$2.3M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Thor Bjorgolfsson
Angel
|
2 | United Kingdom, Germany | Seed, Series A, Series C | Big Data, TV, B2B | $26M–$26M |
|
Wille Finance
VC Fund
|
1 | Germany, Switzerland, France | Seed, Series A, Series C | Health Care, Biotechnology, SaaS | |
|
Teknoloji Yatirim
VC Fund
|
1 | Turkey, United States, Germany | Seed, Series A, Convertible Note | Software, Machine Learning, Analytics | |
|
Pillar VC
VC Fund
|
1 | United States, Spain, Israel | Seed, Series A | Software, Biotechnology, Health Care | |
|
Günther Strunk
Angel
|
1 | Germany | Pre-Seed | Video Games, Life Science, Therapeutics | |
|
Chorus One
VC Fund
|
1 | United States, Canada, Singapore | Seed, Series A | Blockchain, Cryptocurrency, Software | |
|
Medice Arzneimittel
VC Fund
|
1 | Germany | Series A | Veterinary, Life Science, Biotechnology | |
|
ATHOS Service
VC Fund
|
1 | Germany | Series A, Series C | Railroad, Software, Biopharma | |
|
LANA Ventures
VC Fund
|
1 | Austria | Seed | Apps, Medical, mHealth | |
|
BACKED VC
VC Fund
|
1 | United Kingdom, United States, The Netherlands | Seed, Series A | Software, Blockchain, Enterprise Software | |
|
JOT-Berlin
VC Fund
|
1 | Germany | Seed | News, Life Science, Social Media | |
| Access all 268 investors in Germany Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 583
- Round size: Seed $1.1M–$7.3M; Series A $3.5M–$33M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- DcubeD — Accelerate your space exploration through durable and affordable Release Actuators, Solar Arrays, and Deployables from DCUBED.
- FINE Legal — fine. holt Dir Dein Geld einfach, digital und ohne Risiko.
- NAVAN Technologies — NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yetgentle and non-perturbative manne
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 87
- Round size: Seed $365k–$3M; Grant $80k–$165k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, E-Commerce
- Stage:Seed, Pre-Seed
- Geography: Turkey, United Kingdom, Estonia
Investor stats
- Total investments: 34
- Round size: Seed $18k–$697k; Pre-Seed $50k–$100k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — Heybooster is a provider of analytical tools to ecommerce companies to take better digital marketing decisions.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 226
- Round size: Seed $1M–$5.5M; Series A $2.2M–$10M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $33M in 2022
Portfolio highlights
- dentolo — dentolo operates a dental insurance and ecosystem centered around customer needs.With its insurance solution, the company covers 100% in dental, instantly, with best value-for-money, market-leading customer satisfaction and an unmatched modern retail experience within its ecosystem. It addresses consumer demand with dental professionals in 25+regions, reaching 40m+ people nationwide. The company owns proprietary and scalable acquisition channels with the #1 dental guide in DACH and a deeply integrated ecosystem. It relentlessly focuses on customer experience and products that solve real-world pains to make dental care more transparent, affordable, and human.
- Famedly — Der Messenger der Gesundheitsbranche, der auch medizinische Arbeitsprozesse abbildet.
- dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
b.value AG are into Biotechnology investments.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Chemical
- Stage:Seed, Series A
- Geography: Germany, Poland
Investor stats
- Total investments: 14
- Round size: Seed $478k–$2.5M; Series A $3M–$39M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more...Investment focus
- Industry: FinTech, Apps, Social
- Stage:Series A, Series B, Post-IPO Equity
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 6
- Round size: Series A $45M–$157M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 59
- Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Xias Bio — Xias Bio is a biotechnology startup specializing in the production of recombinant proteins, offering formulators advanced soluble, active ingredients with improved attributes such as enhanced gel and film formation, as well as antioxidant properties. The company creates non-immunogenic natural motifs to produce a better delivery platform offunctionalities for research, beauty, and healthcare.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 100
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 204
- Round size: Seed $3.7M–$12M; Series A $10M–$50M; Series B $20M–$150M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- Fuse Energy — Fuse Energy is building the future of energy with cheaper tariffs, better service, and greener goals. Switch to Fuse Energy today
- Atana Elements — Atana is a data-driven resource company that accelerates the exploration and development of flowing critical minerals.
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 83
- Round size: Seed $1.1M–$8M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Patronus Group — Rethinking elderly healthcare
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 32
- Round size: Seed $25k–$7M; Series A $6.7M–$21M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 46
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 93
- Round size: Series A $2M–$12M; Series B $5.1M–$20M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $94M in 2016
Portfolio highlights
- AYOXXA — AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer,allergies, cardiovascular and infectious diseases – in a single test.
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Virtual Reality
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 287
- Round size: Seed $406k–$6.6M; Pre-Seed $100k–$2.6M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- SKETCHAR.io — Sketchar is the ultimate AR drawing app for art creation, learning to draw, and collaborating with 12M people. Try now!
- Nyad —
- Polkadot — Polkadot is a dedicated community that envisions a web where users own their digital identities and data, restoring their authority.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more...Investment focus
- Industry: Software, Analytics, Manufacturing
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 105
- Round size: Seed $650k–$13M; Series A $1M–$38M; Series B $4.3M–$30M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Brale — Combining the best of CeFi & DeFi.
- Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
- Phlair — Carbon Atlantis is producing energy-efficient approach for ocean-based carbon dioxide removal.
hiVC is an early-stage venture capital that connects early-stage startups with winning business models to achieve global success.
Show more...Investment focus
- Industry: SaaS, Mobile, Rental
- Stage:Seed, Pre-Seed, Series A
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 13
- Round size: Seed $175k–$850k; Pre-Seed $200k–$660k
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Kidokit — Kidokit is a child development and parent support application that promotes the growth of infants and kids from one to six years old.
- V-Count — V-Count works with 550+ brands, 25.000+ locations in 105+ countries.
- HoustonBionics — HoustonBionics is proud to introduce ExoRehab X, a revolutionary at home stroke rehabilitation device to help support recovery.
EQT is an investment organization committed to creating value by finding good companies and helping them become the most promising builders of tomorrow.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $46M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 12
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!1kx is an early-stage investment firm focused on ecosystem growth.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 162
- Round size: Seed $1.8M–$11M; Series A $6M–$28M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Bluff —
- Cryptio — We offer enterprise-grade accounting, reporting, and audit software for your digital assets.
- Kulipa — Kulipa provides the underlying infrastructure to settle global payments, manage stablecoin accounts, and issue cards - all through a unified, compliant stack. Grow revenue with debit cards. Boost acquisition with white-labelled accounts & cards. Scale faster with global payment products.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 138
- Round size: Seed $2.3M–$17M; Series A $3.8M–$95M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Industry: Software, Apps, Wellness
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, France
Investor stats
- Total investments: 42
- Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Niantic — Niantic focuses on developing games that encourage outdoor activity and social engagement. It aims to create products for movement, exploration, and face-to-face social interaction. Its notable products include Ingress and Pokémon GO.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Sunnyside — Sunnyside is the #1 alcohol moderation app helping 600,000+ people drink less through tracking, coaching, and optional naltrexone via telehealth. Start your free 15-day trial.
Ersin Pamuksüzer
Show more...Investment focus
- Industry: Education, Life Science, Virtual Reality
- Stage:Seed, Series A
- Geography: Turkey, Germany
Investor stats
- Total investments: 5
- Round size: Seed $300k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aposto — All-in-one media service currently based in Istanbul, Turkey.
- VRLab Academy — VRLab Academy | Virtual Experiments
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 158
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — AtlasEdge is an edge data center business with a mission to create the leading-edge platform, delivering seamless, localized and ultra-low latency digital infrastructure to customers. They provide a wide range of direct connectivity options to enable connectivity within their datacenters. All cabling is installed and managed by AtlasEdge and itsengineering team to ensure speed of installation and guaranteed quality and management.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
Chemovator is an incubator of chemistry businesses. It is the business incubator of BASF.
Show more...Investment focus
- Industry: Software, Manufacturing, Advanced Materials
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$3.7M; Pre-Seed $975k–$2.4M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
- Replique — Replique is an online first fully encrypted 3D printing platform that makes spare part management more sustainable to large OEMs.
- Spark e-Fuels — We build technologies for affordable, scalable and sustainable e-fuels production, to enable net-zero aviation today.
TechOne VC is a venture capital firm. It invests in innovative tech startups founded by visionary entrepreneurs solving global problems, to deliver superior returns for our investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 59
- Round size: Seed $300k–$2.8M; Pre-Seed $30k–$605k
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $4.4M in 2020
Portfolio highlights
- Co-one — Co-one empowers businesses to unlock the full potential of Generative AI. We provide data-driven solutions for LLM development, including evaluation and dataset generation.
- Getmobil — Getmobill offers services in refurbished devices and their sale and resale.
- Atlas Space —
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $2M–$13M; Pre-Seed $500k–$4.3M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ubitium — Ubiquitous computing, universal RISC-V microprocessor
- Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
- Fabric Cryptography — Fabric develops a custom cryptography hardware to accelerate cryptography algorithms. The chips, whose components exclusively serve cryptographic purposes, are based on Verifiable Processing Units (VPUs) which incorporate features of GPUs and ASICs to improve the speed and cost of advanced cryptographic workloads.
Holger Hübner
Show more...Investment focus
- Industry: B2B, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 5
- Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 72
- Round size: Seed $1.6M–$17M; Series A $3.8M–$18M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $121M in 2022
Portfolio highlights
- DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
- Entelo Bio — Precision Medicine
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.
Show more...Investment focus
- Industry: Blockchain, FinTech, Cryptocurrency
- Stage:Seed, Series A
- Geography: United States, India, Germany
Investor stats
- Total investments: 31
- Round size: Seed $953k–$8.5M; Series A $11M–$38M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Curative — Get on-the-go COVID-19 testing and other essential health services, wherever you are.
- Mansa — Built by Black creators with a passion for making culture-positive content, Mansa is the only place to stream the best in Global Black stories
- Galaxy Digital — Galaxy is a digital asset and blockchain leader helping institutions, startups, and individuals shape a changing economy.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Seed $2M–$2.1M; Series A $5.5M–$19M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to build iconic businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 74
- Round size: Seed $3.5M–$18M; Series A $12M–$25M; Series B $10M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Zenskar — Zenskar seamlessly manages complex subscription and usage based billing. Meter high throughput data, and automate revenue accounting, analytics & dunning.
- Mother Games — MOTHER Games is an art and media company that creates transformative experiences through play, blending creativity and innovation to craft unique and engaging interactive experiences.
- Turnout — Turnout Technologies is a technology related company.
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Life Science
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $2M–$9.3M; Series A $10M–$45M; Series B $8.7M–$61M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- NovoNutrients — NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Series A
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 84
- Round size: Seed $1.9M–$9M; Series A $2.8M–$43M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Cryopets — Pausing biological time with cryosleep for pets
- Share — Share operates as an independent and neutral digital infrastructure platform dedicated to advancing Africa’s growth and development. It provides reliable, scalable, and inclusive technological foundations that enable governments, businesses, and communities to build, connect, and innovate.
- Ceramic Network — Ceramic Network is a provider of protocols for decentralized and composable data applications. The network decentralizes application databases, making data universally composable and reusable across applications. It consists of three core parts: a highly-scalable, decentralized infrastructure for data availability and consensus, a marketplace ofcommunity-created data models, and a suite of standard APIs for storing, updating, and retrieving data from those models.
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk. We do this by supporting the wise development of transformative technologies. Our main areas of investment focus are transformative artificial intelligence and frontier mental health technologies.Leading academics estimate a 1-in-6 chance ofhuman extinction by the year 2100, largely driven by risks from emerging technologies. And now, with the exponential growth of AI, predictions are getting worse. Our startups are part of the solution. We invest in exceptional, ethical founders who are developing transformative technologies that have the potential to impact humanity on a meaningful scale, while generating attractive returns for our LPs.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 39
- Round size: Seed $1.6M–$11M; Series A $25k–$46M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Piramidal — Piramidal offers artificial intelligence software that transforms brain activity into easy-to-understand health data to help diagnose neurological diseases.
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
Investitionsbank Berlin (IBB) is the subsidy bank of the Federal Land of Berlin. With its newly orientated economic support and subsidy policy, it actively contributes towards developing Berlin as a business and industry location.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Grant, Seed
- Geography: Germany, Canada
Investor stats
- Total investments: 59
- Round size: Seed $598k–$2.3M; Grant $19k–$1.4M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Quantune — Quantune is a deep tech startup in optics and photonics technology. It develops laser spectrometer for continuous and non-invasive health monitoring.
- Level Nine — Level Nine specializes in bio-nanotechnology and quantum chemistry, developing next-generation catalysts known as nanozymes.
- muffintech — Generative AI for the insurance industry. Unleash the full potential of your employees and offer your customers an unmatched user experience.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 170
- Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- Future Fertility — OUR AI-POWERED ASSESSMENTS GUIDE PERSONALIZED FERTILITY TREATMENT DECISIONS IN OVER 180 CLINICS ACROSS 32 COUNTRIES
- ApoGen Biotechnologies — ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapieseventually fail due to the development of drug resistance. Mutation of cellular DNA is central to the formation of cancer, and chronic mutation of the cancer genome is a primary cause of cancer evolution and drug resistance, resulting in ineffective therapy, cancer recurrence and metastasis, and decreased overall survival.
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more...Investment focus
- Industry: Big Data, TV, B2B
- Stage:Seed, Series A, Series C
- Geography: United Kingdom, Germany
Investor stats
- Total investments: 6
- Round size: Series A $26M–$26M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!An international, Swiss-based family office, focusing on private equity (venture & buy-out), real estate and listed assets.
Show more...Investment focus
- Industry: Health Care, Biotechnology, SaaS
- Stage:Seed, Series A, Series C
- Geography: Germany, Switzerland, France
Investor stats
- Total investments: 31
- Lead/follow: no public data
Portfolio highlights
- Supervizor — Supervizor allows companies to automatically check all accounting and operational data, and detect errors and fraud. No setup or dry runs required.
- StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
- SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
Teknoloji Yatırım is the first actor investing in early-stage technology companies in Turkey. Aiming at preparing the venture capital ecosystem for new players, Teknoloji Yatırım designs, develops and manages innovative tools to meet the financing needs of technology companies in the early and growth stages. What We Do: - Direct Investments: Wemake equity investments to technology companies having internationalization potential. - Co-Investments and Follow-on Investments: We make co-investments and follow-on investments to technology companies at scaling and growth stages, together with other Venture Capital Funds. - Consultancy Services: We offer consultancy solutions in the design, implementation and management of innovative investment tools and models.
Show more...Investment focus
- Industry: Software, Machine Learning, Analytics
- Stage:Seed, Series A, Convertible Note
- Geography: Turkey, United States, Germany
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- Cellsway — Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development ofmicrofluidics and lab-on-a-chip technologies for biomedical purposes.
- BRANDEFENSE — Brandefense platform is a proactive digital risk protection solution for organizations. Our AI-driven technology constantly scans the dark, deep, and surface web.
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
Pillar VC is a pre-seed and seed venture capital firm that invests in technical breakthroughs and exceptional founders.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United States, Spain, Israel
Investor stats
- Total investments: 147
- Lead/follow: no public data
Portfolio highlights
- Acelab — Discover and compare over 25,000 building products with Acelab. Find the best solutions for your construction projects. Explore our catalog today.
- Tycho AI — Tycho AI delivers autonomous intelligence with AI that acts independently, adapts in real time, and drives mission outcomes at the edge.
- Addis Energy — Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production.
Günther Strunk
Show more...Investment focus
- Industry: Video Games, Life Science, Therapeutics
- Stage:Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
Chorus One is offering staking services and building tools and protocols to advance the Proof of Stake ecosystem.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A
- Geography: United States, Canada, Singapore
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Keplr — Introducing the first, and leading, IBC-enabled wallet for Cosmos and beyond
- FastLane — The Alignment Layer of Monad - shMonad is the holistic LST returning value to Nads, apps, and validators
- Fortytwo — Fortytwo is a decentralized AI network that employs swarm intelligence by linking consumer devices to execute small AI models. It provides a scalable and cost-efficient alternative to centralized AI systems, enabling users to contribute computing resources while ensuring data privacy. Fortytwo's goal is to create a reasoning engine thatoperates on a planetary scale and is driven by the community.
MEDICE is one of the most successful family-owned pharmaceutical companies in Germany. Committed to the fundamental ethical values of medicine, MEDICE has been demonstrating for almost 70 years that humanity and confidence are a strong basis for innovation and growth.
Show more...Investment focus
- Industry: Veterinary, Life Science, Biotechnology
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
ATHOS Service GmbH is the family office of Thomas und Andreas Strüngmann. ATHOS Service GmbH is based in Munich, Germany.
Show more...Investment focus
- Industry: Railroad, Software, Biopharma
- Stage:Series A, Series C
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KONUX — KONUX combines Machine Learning algorithms and IoT to deliver software-as-a-service solutions for operation, monitoring, and maintenance process automation
- BioNTech — BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates.
LANA Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Apps, Medical, mHealth
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
BACKED is the human-centric venture capital fund. We invest in exceptional founders at Seed in Europe. Welcome to Different.
Show more...Investment focus
- Industry: Software, Blockchain, Enterprise Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 91
- Lead/follow: no public data
Portfolio highlights
- JUST — JUST is a company that specialises in ecommerce payment solutions.
- Affinity — Join over 70,000 who trust the Affinity mobile app to manage your personal banking needs and qualify for an Affinity Instant Loan
- Cloud Capital — CloudCapital manages cloud costs and invests in tech companies using AI and ML.
Jot-Berlin is a group of angel investors.
Show more...Investment focus
- Industry: News, Life Science, Social Media
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Life Science Investor funding in Germany at a glance
Stats across 142 deals from 268 investors.
Access all 268 investors in Germany Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 268 investors investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!